It works by targeting two hormones, GIP and GLP-1 , which help the body manage blood sugar, reduce hunger, and increase feelings of fullness
The FDA approved an oral formulation in 2019 and then expanded approval of the peptides injection formulation in 2021 to include weight management for those suffering from at least one weight-related condition, such as type 2 diabetes or high cholesterol
Clinical evidence suggests that whilst these medicines do not directly damage the eyes, they may be associated with worsening diabetic retinopathy in certain patients, particularly those with pre-existing eye disease who experience rapid improvements in blood glucose control
Your provider and genetic profile can help determine the best approach
Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells